Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunotherapy and potential predictive biomarkers in the treatment of neuroendocrine neoplasia.

Future oncology (London, England) - 1 Mar 2021

Xu Guanghui, Wang Yuhao, Zhang Hushan, She Xueke, Yang Jianjun

Abstract excerpt

Neuroendocrine neoplasias (NENs) are a heterogeneous group of rare tumors scattered throughout the body. Surgery, locoregional or ablative therapies as well as maintenance treatments are applied in well-differentiated, low-grade NENs, whereas cytotoxic chemotherapy is usually applied in high-grade neuroendocrine carcinomas. However, treatment options for patients with advanced or metastatic NENs are limited....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Carcinoma, Merkel Cell
Share to Digestive System Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immune Checkpoint Inhibitors

Share to Immunotherapy

Share to Lymphocytes, Tumor-Infiltrating

Share to Microsatellite Instability

Share to Neuroendocrine Tumors

Source

Identifiers

PMID: 33136448
DOI: 10.2217/fon-2020-0703

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunotherapy and potential predictive biomarkers in the treatment of neuroendocrine neoplasia.PMID 33136448Read ↗

Esophageal neuroendocrine carcinoma: molecular insights, diagnostic advances, and emerging treatment strategies.Semantic proximity Read ↗

Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?Semantic proximity Read ↗

Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasmsSemantic proximity Read ↗

The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms.Semantic proximity Read ↗

Pathologic Classification of Neuroendocrine Neoplasms.Semantic proximity Read ↗

Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the FutureSemantic proximity Read ↗

Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot StudySemantic proximity Read ↗

Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.Semantic proximity Read ↗

Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.Semantic proximity Read ↗

Concept of neuroendocrine neoplasms of all organs with a focus on grading, subtyping.Semantic proximity Read ↗

Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review.Semantic proximity Read ↗

Preclinical Models of Neuroendocrine NeoplasiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.